The Microbiome Center, Department of Surgery, University of Chicago, Chicago, USA.
The Microbiome Center, Department of Surgery, University of Chicago, Chicago, USA; Biosciences Division, Argonne National Laboratory, Lemont, IL, USA.
Curr Opin Biotechnol. 2018 Jun;51:146-153. doi: 10.1016/j.copbio.2018.01.018. Epub 2018 Feb 14.
Recent research has shown that the microbiome-a collection of microorganisms, including bacteria, fungi, and viruses, living on and in a host-are of extraordinary importance in human health, even from conception and development in the uterus. Therefore, to further our ability to diagnose disease, to predict treatment outcomes, and to identify novel therapeutics, it is essential to include microbiome and microbial metabolic biomarkers in Systems Biology investigations. In clinical studies or, more precisely, Systems Medicine approaches, we can use the diversity and individual characteristics of the personal microbiome to enhance our resolution for patient stratification. In this review, we explore several Systems Medicine approaches, including Microbiome Wide Association Studies to understand the role of the human microbiome in health and disease, with a focus on 'preventive medicine' or P4 (i.e., personalized, predictive, preventive, participatory) medicine.
最近的研究表明,微生物组——包括细菌、真菌和病毒在内的微生物集合,存在于宿主的体表和体内——对人类健康具有非凡的重要性,甚至从子宫内的受孕和发育阶段就开始产生影响。因此,为了进一步提高我们诊断疾病、预测治疗效果和发现新疗法的能力,在系统生物学研究中纳入微生物组和微生物代谢生物标志物是至关重要的。在临床研究中,或者更准确地说,在系统医学方法中,我们可以利用个人微生物组的多样性和个体特征来提高患者分层的分辨率。在这篇综述中,我们探讨了几种系统医学方法,包括微生物组关联研究,以了解人类微生物组在健康和疾病中的作用,重点关注“预防医学”或 P4(即个性化、预测性、预防性、参与性)医学。